SUBSCRIBE
SUBSCRIBE
News   Drug Development

Dendreon Corporation Sees Positive Results From Provenge

November 10, 2006 | 
1 min read

NEW YORK, Nov 10 (Reuters) - Dendreon Corp. (DNDN.O: Quote, Profile, Research) said on Friday analysis of its Provenge immunotherapy for the treatment of advanced prostate cancer showed positive results.

>>> Discuss This Story

Clinical research Postmarket research
MORE ON THIS TOPIC
Young White Woman at home Holding Two Pain Killer Pills in Her Hand Palm After Spilling from Bottle and Glass of Water. Concept of Pain Relief, Addiction to Opioids and NSAIDs
Pain
Algiax’s Non-Opioid Drug Reduces Neuropathic Pain in Mid-Stage Trial
February 4, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Courtesy of 400tmax/Getty Images
Cystic Fibrosis
Cystic Fibrosis Biotech Sionna Announces $150M IPO
February 3, 2025
 · 
1 min read
 · 
Dan Samorodnitsky
Abstract vector storm clouds with thunder hand drawn chaotic tangle of doodles.Sign bad weather,impending rain and storm,thunder rolls.Symbol stress,depression,psychosis,mental crisis personality,headache after suffering coronavirus.
Psychedelics
GH’s Inhaled Psychedelic Succeeds in Mid-Stage Depression Trial
February 3, 2025
 · 
2 min read
 · 
Dan Samorodnitsky
Peera_Sathawirawong/Getty Images
Partnered
The APAC Opportunity: Why Clinical Trials Are Shifting East
February 3, 2025
 · 
7 min read
 · 
BioSpace Insights